|
28.07.2023 08:17:52
|
EQS-News: Vitruvia Medical AG: Shareholders approved all proposals at the Annual General Meeting of Shareholders
|
EQS-News: VITRUVIA MEDICAL AG
/ Key word(s): AGM/EGM
Vitruvia Medical AG announces that the Company's shareholders approved all proposals on the agenda of the Annual General Meeting held in Baden (AG) on July 26, 2023. A total of 1,110,582 voting shares, representing 44.2% of the total share capital, were represented at this Annual General Meeting.
Markus A. Bertschin, Chairman of the Board of Directors thanked the shareholders for their trust in our company and welcomed our new Board member Mr. Claus Wiest, Managing Director of our investment LT technologies GmbH & Co. KG.
Vitruvia Medical AG
Board of Directors
28.07.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Vitruvia Medical AG |
| Kesselackerstr. 18 | |
| 5611 Anglikon | |
| Switzerland | |
| Phone: | +41 44 915 33 78 |
| E-mail: | kontakt@vitruvia-med.com |
| Internet: | www.vitruvia-med.com |
| ISIN: | CH0461931419 |
| WKN: | A2PDWF |
| Listed: | Regulated Unofficial Market in Munich |
| EQS News ID: | 1690515 |
| End of News | EQS News Service |
|
|
1690515 28.07.2023 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu VITRUVIA MEDICAL AGmehr Nachrichten
|
25.07.24 |
EQS-Adhoc: Vitruvia Medical AG: Halbjahresergbnis per 30. Juni 2024 (EQS Group) | |
|
25.07.24 |
EQS-Adhoc: Vitruvia Medical AG: Half yearly results as per June 30th, 2024 (EQS Group) |
Analysen zu VITRUVIA MEDICAL AGmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.